|
|
||||||||
1 Department of Pediatrics, Children's Hospital and Regional Medical Center, Seattle 98105; and Departments of 2 Medicine, 3 Anesthesiology, and 4 Environmental Health, University of Washington, Seattle, Washington 98108
We investigated the source(s) for exhaled nitric oxide (NO) in isolated, perfused rabbits lungs by using isozyme-specific nitric oxide synthase (NOS) inhibitors and antibodies. Each inhibitor was studied under normoxia and hypoxia. Only nitro-L-arginine methyl ester (L-NAME, a nonselective NOS inhibitor) reduced exhaled NO and increased hypoxic pulmonary vasoconstriction (HPV), in contrast to 1400W, an inhibitor of inducible NOS (iNOS), and 7-nitroindazole, an inhibitor of neuronal NOS (nNOS). Acetylcholine-mediated stimulation of vascular endothelial NOS (eNOS) increased exhaled NO and could only be inhibited by L-NAME. Selective inhibition of airway and alveolar epithelial NO production by nebulized L-NAME decreased exhaled NO and increased hypoxic pulmonary artery pressure. Immunohistochemistry demonstrated extensive staining for eNOS in the epithelia, vasculature, and lymphatic tissue. There was no staining for iNOS but moderate staining for nNOS in the ciliated cells of the epithelia, lymphoid tissue, and cartilage cells. Our findings show virtually all exhaled NO in the rabbit lung is produced by eNOS, which is present throughout the airways, alveoli, and vessels. Both vascular and epithelial-derived NO modulate HPV.
nitric oxide synthase inhibitors; isolated perfused lung; 1400W; 7-nitroindazole; nitro-L-arginine methyl ester
This article has been cited by other articles:
![]() |
T. Stuber, C. Sartori, C. S. Salmon, D. Hutter, S. Thalmann, P. Turini, P.-Y. Jayet, M. Schwab, C. Sartori-Cucchia, M. Villena, et al. Respiratory Nitric Oxide and Pulmonary Artery Pressure in Children of Aymara and European Ancestry at High Altitude Chest, November 1, 2008; 134(5): 996 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. T. Demchenko, K. E. Welty-Wolf, B. W. Allen, and C. A. Piantadosi Similar but not the same: normobaric and hyperbaric pulmonary oxygen toxicity, the role of nitric oxide Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L229 - L238. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hampl, J. Bibova, A. Banasova, J. Uhlik, D. Mikova, O. Hnilickova, V. Lachmanova, and J. Herget Pulmonary vascular iNOS induction participates in the onset of chronic hypoxic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L11 - L20. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Berger, C. Hesse, C. Dehnert, H. Siedler, P. Kleinbongard, H. J. Bardenheuer, M. Kelm, P. Bartsch, and W. E. Haefeli Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 763 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Girgis, H. C. Champion, G. B. Diette, R. A. Johns, S. Permutt, and J. T. Sylvester Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension: Response to Bosentan Therapy Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 352 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liu, O. V. Evgenov, and F. Ichinose NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice J Appl Physiol, February 1, 2005; 98(2): 748 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Lane, D Knight, S Burgess, P Franklin, F Horak, J Legg, A Moeller, and S Stick Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath Thorax, September 1, 2004; 59(9): 757 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Belik, J. Pan, R. P. Jankov, and A. K. Tanswell A bronchial epithelium-derived factor reduces pulmonary vascular tone in the newborn rat J Appl Physiol, April 1, 2004; 96(4): 1399 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Schwartz, C. A. White, and B. A. Freeman Do we kNOw how HSP90 and eNOS mediate lung injury in sickle cell disease? Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L701 - L704. [Full Text] [PDF] |
||||
![]() |
J. W. Skimming, O. Nasiroglu, C.-J. Huang, C. E. Wood, B. R. Stevens, I. U. L. Haque, P. O. Scumpia, and P. J. Sarcia Dexamethasone suppresses iNOS yet induces GTPCH and CAT-2 mRNA expression in rat lungs Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L484 - L491. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |